'Phase' Searchterm 'Phase' found in 77 articles 4 terms [ • ] - 73 definitions [• ] Result Pages : •
Phase in ultrasound describes where the sound wave is in its cycle of amplitude change. Different waves oscillate at different frequencies, so time is often not a suitable measure of phase. The phase shift is a difference in the phase or the temporal offset of the peaks of a waveform along one scan line. See also Coherence, and Histogram. • •
Different stages of testing drugs in humans for example ultrasound contrast agents, from first application in humans through limited and broad clinical tests, to postmarketing studies. Preclinical trials are the testing in animals.
•
Phase I: Safety, pharmacokinetics
•
Phase II: Dose
•
Phase III: Efficacy
•
Phase IV: Postmarketing
See also Drug Development and Approval Process USA, Food and Drug Administration, and European Medicines Agency. •
Dual frequency phased array transducers allow performing third or fourth harmonic imaging. This array design contains two different types of elements arranged in an interleaved pattern (odd and even elements). The elements can work individually and at a distinct frequency enabling separate transmission and receiving modes.
•
Different stages of the drug development and approval process in the USA, lead from preclinical trials (testing in animals), first application in humans through limited and broad clinical tests, to postmarketing studies.
Years
Test Population
Purpose
Success Rate
Preclinical Testing
3.5
Laboratory and animal studies
Assess safety and biological activity
5,000 compounds evaluated
Phase II
2
100 to 300 patient volunteers
Evaluate effectiveness, look for side effects
Phase III
3
1000 to 3000 patient volunteers
Verify effectiveness, monitor adverse reactions from long-term use
12 Total
By Dale E. Wierenga, Ph.D. and C. Robert Eaton Office of Research and Development Pharmaceutical Manufacturers Association 'In reviewing this report, it is important to keep in mind the realities of the drug discovery and development process. The U.S. system of new drug approvals is perhaps the most rigorous in the world. On average, it costs a company $359 million to get one new medicine from the laboratory to the pharmacist's shelf, according to a February 1993 report by the Congressional Office of Technology Assessment.' See also Phase 1 2 3 4 Drug Trials, Food and Drug Administration, and European Medicines Agency. Result Pages : |